[Case of osteomalacia due to intravenous saccharated ferric oxide].
Nakaoka
T
T
Sugimoto
T
T
Okimura
Y
Y
Chihara
K
K
D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D015519:Bone Density; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D005293:Ferritins / Q000378:metabolism; D006801:Humans; D007262:Infusions, Intravenous; D010018:Osteomalacia / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D010758:Phosphorus / Q000378:metabolism
D005290:Ferric Compounds; C000499:ferric oxide; D010758:Phosphorus; D005293:Ferritins; D000469:Alkaline Phosphatase